Online ISSN: 1945-4589
About Aging
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

An Original Review on the Hallmarks of Cancer and Aging

Aging

May 19, 2022
Dr. Mikhail Blagosklonny published an original review paper in Aging (Aging-US) Volume 14, Issue 9, entitled, “Hallmarks of cancer and hallmarks of aging.” continue reading »

Aging-US: Hallmarks of Cancer and Hallmarks of Aging

Aging

May 18, 2022
PRESS RELEASE: Dr. Mikhail Blagosklonny published a new review paper in Aging (Aging-US), entitled, “Hallmarks of cancer and hallmarks of aging.” continue reading »

Aging-US: New Insights on Skin Aging Gleaned From Naked Mole-Rats

News

May 17, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging, entitled, “Single-cell transcriptomics reveals age-resistant maintenance of cell identities, stem cell compartments and differentiation trajectories in long-lived naked mole-rats skin.” continue reading »

Dr. Blagosklonny’s Rapamycin-Based Recommendation for Altos Labs

Aging

May 12, 2022
Mikhail Blagosklonny, M.D., Ph.D., has a recommendation for Altos Labs in his new research perspective, entitled, “Altos Labs and the quest for immortality: but can we live longer right now?” continue reading »

TP53 Restoration Sensitizes Pancreatic Cancer to Multiple Drugs

Aging

May 5, 2022
In Aging’s Volume 14, Issue 8, cover paper, researchers found that the restoration of wild-type TP53 decreased pancreatic cancer cell resistance to various drugs, including rapamycin. continue reading »